Dr. Kevin D. Cannon, MD

Dr. Cannon practices at New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina.

Dr. Cannon's NPI, 1700897022, was assigned on August 11, 2006. Dr. Cannon graduated from Virginia Commonwealth University, School of Medicine in 1997. Dr. Cannon holds North Carolina license 13188.

Dr. Cannon's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit, at 2131 South 17th Street, Wilmington, NC 28402 in New Hanover County. The practice phone is (910) 667-5619.

Dr. Cannon's primary practice is New Hanover Regional Medical Center Rehabilitation - Unit in Wilmington, North Carolina. Dr. Cannon is also affiliated with Novant Health New Hanover Regional Medical Center. The medical group on file is Wilmington Health. Dmand AI also links Dr. Cannon to 1 more behavioral health center, 1 breast imaging center and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cannon practices, 5 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Cannon's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dr. Cannon is licensed in North Carolina.

CMS data shows 314 Medicare services from Dr. Cannon across 3 procedure codes in 2024, for 114 Medicare patients. Medicare paid $21,243 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Cannon in 2024. The largest group is 75 to 84, with 55 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cannon's median patient age at 73, with 54% women.

In 2024, Dr. Cannon wrote 182 Medicare Part D claims for 62 patients. 76% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $19 in total drug cost. In 2023, CMS named 25 claims across 2 drugs.

Dr. Cannon accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Cannon, published from 2016 to 2024. 2021 was the busiest year, with 3. The most frequent topics are Double-Blind Method, COVID-19 and Influenza Vaccines. Dr. Cannon has published most often in N Engl J Med. Dr. Cannon's most frequent co-authors are Hessam Aazami, MD, Gerard Frantz Acloque, MD and Shazia Ali, MD.

Dmand AI links Dr. Cannon to 9 clinical trials, 3 of them phase 1/2 studies. Conditions studied include COVID-19, Pneumonia, Viral and Osteoarthritis, Hip. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Cannon that name 5 trials.

CMS Open Payments shows 89 general payments to Dr. Cannon from 11 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 68% of the total. Novo Nordisk AS paid the most, $12,903. It also lists 97 research payments totaling $44,528 from 2016 to 2025, naming 5 clinical trials.

Dr. Cannon graduated from Virginia Commonwealth University, School of Medicine in 1997.